Heart valve procedure: who might face problems later?

NCT ID NCT07191093

Ongoing Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 50 people who had a minimally invasive procedure to widen a narrowed heart valve (pulmonary balloon valvuloplasty). The goal is to see how often the right side of the heart struggles afterward and what factors might predict that. Researchers will track changes in heart function over time using ultrasound and other measures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pulmonary balloon valvuloplasty (a catheter procedure to widen a narrowed heart valve)
What this could lead to: If successful, this could help doctors identify patients at higher risk for heart dysfunction after the procedure, potentially improving follow-up care.
What could go wrong: This is a small, observational study with only 50 participants, so results may not apply to everyone. It does not test a new treatment, only looks for patterns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital pulmonary valve stenosis pulmonary valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULMONARY VALVULOPLASTY RV DYSFUNCTION

Contacts and locations

Locations

Assiut University

Asyut, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.